MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Depomed Company Profile (NASDAQ:DEPO)

Consensus Ratings for Depomed (NASDAQ:DEPO) (?)
Ratings Breakdown: 2 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $23.10 (14.75% upside)

Analysts' Ratings History for Depomed (NASDAQ:DEPO)
Show:
DateFirmActionRatingPrice TargetActions
5/17/2016Janney Montgomery ScottReiterated RatingBuy$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2016MizuhoUpgradeNeutral -> Buy$18.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016Piper JaffrayLower Price TargetOverweight$23.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016RBC CapitalReiterated RatingSector Perform$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2016Leerink SwannReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2016Northland SecuritiesInitiated CoverageOutperform$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016WallachBeth CapitalLower Price TargetBuy$33.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015Morgan StanleyInitiated CoverageEqual -> Equal Weight$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/24/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha